Trial Profile
The SLIM Study: Sling and Botox Injection for Mixed Urinary Incontinence
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Mar 2023
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Urinary incontinence
- Focus Therapeutic Use
- Acronyms SLIM
- 26 Jul 2021 Status changed from active, no longer recruiting to completed.
- 03 Dec 2020 Primary endpoint (Self-reported mixed urinary incontinence symptoms) has not been met, according to results published in the Obstetrics and Gynecology
- 03 Dec 2020 Results published in the Obstetrics and Gynecology